Clindamycin Hydrochloride
Who holds supplier records for Clindamycin Hydrochloride? 11 organisations hold a current record for Clindamycin Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (6), India (2) and Italy (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Clindamycin Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/clindamycin-hydrochloride
Reading the evidence
- 11 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in China
6 of the 9 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (11)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Clindamycin Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CHONGQING CARELIFE PHARMACEUTICAL CO LTDChinaCEPActive DMF 13787 · latest filing Sept 1998
- Hubei Yitai Pharmaceutical Co., LtdChinaCEPActive DMF 31876 · latest filing Aug 2017
- Xinyu Pharmaceutical Co., Ltd.ChinaCEPActive DMF 32342 · latest filing Jan 2018
- Zhejiang Tiantai Pharmaceutical Co., Ltd.ChinaCEPActive DMF 20450 · latest filing Mar 2007
- ALCHYMARS ICM SM PRIVATE LTDIndiaActive DMF 19176 · latest filing Feb 2006
- NANYANG PUKANG PHARMACEUTICAL CO LTDActive DMF 20971 · latest filing Oct 2007
- Zhejiang Hisoar Pharmaceutical Co., Ltd.ChinaActive DMF 27266, 16815 · latest filing Jul 2013
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 19225 · latest filing Mar 2006
- ACS DOBFAR SPAItalyCEP Company GMP cert on recordInactive DMF 18704 · latest filing Aug 2005
- ESTEVE QUIMICA SACEP Company GMP cert on record
- Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (7)
Certificates of Suitability on the EDQM register for Clindamycin Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HUBEI YITAI PHARMACEUTICAL CO., LTD. Tianmen | CN | CEP 2021-013 - Rev 01 Clindamycin hydrochloride | Jun 2026 | — |
| CHONGQING CARELIFE PHARMACEUTICAL CO., LTD. Chongqing | CN | CEP 2024-484 - Rev 00 Clindamycin hydrochloride, Process C | Mar 2025 | — |
| ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2013-190 - Rev 02 Clindamycin hydrochloride, BTC Process | Sept 2024 | Inspected Jan 2024 Germany |
| ZHEJIANG TIANTAI PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2010-281 - Rev 04 Clindamycin hydrochloride | Mar 2024 | — |
| XINYU PHARMACEUTICAL CO., LTD. Suzhou City | CN | R0-CEP 2022-223 - Rev 00 Clindamycin hydrochloride | Aug 2023 | — |
| ESTEVE QUIMICA S.A. Barcelona | ES | R1-CEP 2000-041 - Rev 09 Clindamycin hydrochloride | Mar 2022 | — |
| ACS DOBFAR S.P.A. Tribiano | IT | R1-CEP 2002-132 - Rev 03 Clindamycin hydrochloride | Apr 2018 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (8)
Organisations whose Type II DMFs for Clindamycin Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 8 historical records
- India · Inactive DMF 25901 · filed Apr 2012
- SUZHOU NUMBER 4 PHARMACEUTICAL FACTORYInactive DMF 18778, 21083 · filed Oct 2007
- Spain · Inactive DMF 14539 · filed Nov 1999
- United States · Inactive DMF 13371 · filed Sept 1998
- SHENZHENInactive DMF 13769 · filed Sept 1998
- USA · Inactive DMF 13702 · filed Sept 1998
- BIOCHIMICA OPOS SPAInactive DMF 14260 · filed Jul 1995
- AMERICAN CHEMICAL INDUSTRIAL CORPInactive DMF 7289 · filed Jan 1988
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Clindamycin Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200588).
Chemical identity
- IUPAC name
- (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride
- Canonical SMILES
- CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl.Cl
- InChIKey
- AUODDLQVRAJAJM-XJQDNNTCSA-N
- Synonyms
- Antirobe, Cleocin, Cleocin hydrochloride, Clindamycin (as hydrochloride), Clindamycin hcl, Clindamycin hydrochloride, Clinsol, Clintabs, Dalacin c, NSC-756696, Sobelin, 7-Chloro-7-deoxylincomycin hydrochloride
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Lincosamide Antibacterial
- Physiologic effect
- Decreased Sebaceous Gland Activity; Neuromuscular Blockade
- Chemical structure
- Lincosamides
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Clindamycin Hydrochloride?
11 organisations hold an active US FDA Type II Drug Master File or a CEP for Clindamycin Hydrochloride: CHONGQING CARELIFE PHARMACEUTICAL CO LTD (China), Hubei Yitai Pharmaceutical Co., Ltd (China), Xinyu Pharmaceutical Co., Ltd. (China), Zhejiang Tiantai Pharmaceutical Co., Ltd. (China), ALCHYMARS ICM SM PRIVATE LTD (India), NANYANG PUKANG PHARMACEUTICAL CO LTD, Zhejiang Hisoar Pharmaceutical Co., Ltd. (China) and Zydus Lifesciences Limited (India), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Clindamycin Hydrochloride Drug Master Files are active?
CHONGQING CARELIFE PHARMACEUTICAL CO LTD (DMF 13787), Hubei Yitai Pharmaceutical Co., Ltd (DMF 31876), Xinyu Pharmaceutical Co., Ltd. (DMF 32342), Zhejiang Tiantai Pharmaceutical Co., Ltd. (DMF 20450), ALCHYMARS ICM SM PRIVATE LTD (DMF 19176), NANYANG PUKANG PHARMACEUTICAL CO LTD (DMF 20971), Zhejiang Hisoar Pharmaceutical Co., Ltd. (DMF 27266, 16815) and Zydus Lifesciences Limited (DMF 19225). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Clindamycin Hydrochloride records mean?
8 organisations have only inactive Type II DMFs for Clindamycin Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Clindamycin Hydrochloride have a European Certificate of Suitability?
Yes. 7 organisations hold a valid CEP for Clindamycin Hydrochloride on the EDQM register, including HUBEI YITAI PHARMACEUTICAL CO., LTD. Tianmen (CN), CHONGQING CARELIFE PHARMACEUTICAL CO., LTD. Chongqing (CN), ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO., LTD. Taizhou City (CN), ZHEJIANG TIANTAI PHARMACEUTICAL CO., LTD. Taizhou City (CN), XINYU PHARMACEUTICAL CO., LTD. Suzhou City (CN) and ESTEVE QUIMICA S.A. Barcelona (ES) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Clindamycin Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Clindamycin Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.